apollo
logo
0Login
Introducing Our Latest Arrival!
Hepalair Injection 10 ml

Hepalair Injection 10 ml

Prescription drug
 Trailing icon
Consult Doctor

Manufacturer/Marketer

Leeford Healthcare Ltd

Consume Type

PARENTERAL

Return Policy

Not Returnable

Expires on or after

Apr-26

for this medicine

About Hepalair Injection

Hepalair Injection is used to treat liver diseases such as hepatitis, fatty liver, jaundice, liver cirrhosis, and hepatic encephalopathy. It is indicated to treat different levels of mental and movement function loss (evident and latent hepatic encephalopathy) caused by liver failure. 
 
Hepalair Injection contains L-ornithine-L-aspartate that facilitates the removal of ammonia by increasing glutamine and urea synthesis in the liver and synthesis of glutamine in brain and muscle tissues.
 
Sometimes, Hepalair Injection may cause side effects such as nausea and vomiting. Most of these side effects do not require medical attention and will resolve gradually over time. However, you are advised to talk to your doctor if the side effects persist or worsen.
 
Inform your doctor if you are pregnant or breastfeeding before taking Hepalair Injection. Limited information is available regarding the usage of Hepalair Injection in children; please consult your doctor if you have any concerns. Inform your doctor about your medical history and the medicines you take to rule out any side effects/interactions.

Uses of Hepalair Injection

Treatment of Liver diseases include hepatitis, fatty liver, jaundice, liver cirrhosis, and hepatic encephalopathy

Medicinal Benefits

Hepalair Injection is used to treat liver diseases such as hepatitis, fatty liver, jaundice, liver cirrhosis, and hepatic encephalopathy. It is indicated to treat different levels of mental and movement function loss (evident and latent hepatic encephalopathy) caused by liver failure. Hepalair Injection contains L-ornithine-L-aspartate that removes ammonia by increasing glutamine and urea synthesis in the liver and synthesis of glutamine in brain and muscle tissues. Hepalair Injection converts toxic, harmful ammonia into non-toxic urea, eliminated via the urine. It serves as a stimulus for hepatic glutamine synthesis that could be defective in acute and chronic liver disease. Hepalair Injection helps improve psychometric function in patients with hepatic encephalopathy.

Directions for Use

Hepalair Injection will be administered by a healthcare professional; do not self-administer.

Storage

Store in a cool and dry place away from sunlight

Side Effects of Hepalair Injection

  • Nausea
  • Vomiting

Drug Warnings

Do not take Hepalair Injection if you are allergic to any of its components or have renal failure. Consult your doctor if you are pregnant or breastfeeding. Limited information is available regarding the usage of Hepalair Injection in children; please consult your doctor if you have any concerns. Let your doctor know if you are taking prescription/non-prescription medicines, supplements or herbal products.

Drug Interactions

Drug-Drug Interactions: No interactions found/established.

Drug-Food Interactions: No interactions found/established.

Drug-Disease Interactions: No interactions found/established.

Habit Forming

No

Diet & Lifestyle Advise

  • Avoid alcohol consumption.
  • Maintain a healthy weight by exercising regularly.
  • Drink plenty of water.
  • Adopt a liver-friendly diet such as fibre-rich food.
  • Cut down on fats, sugar, and salt.
  • Quit smoking.
  • Avoid stress by practising yoga or meditation. 
  • Exercise regularly as it helps in reducing the accumulation of fat.

Special Advise

  • Regular monitoring of urea levels in urine and serum is advised if Hepalair Injection is used in high doses.

Disease/Condition Glossary

Hepatitis: It occurs due to viral infection leading to liver damage and inflammation, making it difficult for the liver to function properly. Symptoms include yellowing of the skin and eyes, nausea, fatigue, abdominal pain, fever, and nausea.

Fatty liver: Fatty liver occurs due to increased build-up of fat in the liver. It could occur due to excess consumption of alcohol (alcoholic fatty liver) or other factors (non-alcoholic fatty liver). Symptoms include abdominal pain, nausea, oedema, weakness, loss of appetite, and yellowing skin and eyes.

Liver cirrhosis: It is the damage of the liver which causes scarring and liver failure. Symptoms include loss of appetite, tiredness, weakness, weight loss, nausea, vomiting, itchy skin, and yellowing of the skin and eyes.

Jaundice: It occurs due to the build-up of bilirubin in the blood, which causes the yellowing of skin and eyes. Symptoms include yellowing skin and eyes, dark urine, loss of appetite, fatigue, bloody or dark stools, nausea, and vomiting. 

Hepatic encephalopathy: It is a liver disease in which the liver does not remove the toxins from the body, leading to brain function loss. Symptoms include anxiety, irritability, cognitive impairment, problems with balance, difficulty concentrating, mood changes, and muscle twitches.

bannner image

Alcohol

Consult your doctor

It is not known if alcohol affects Hepalair Injection. Please consult your doctor.

bannner image

Pregnancy

Caution

There are no controlled studies on the use of Hepalair Injection during pregnancy. Consult your doctor if you are pregnant or have any concerns; your doctor will prescribe this medicine during pregnancy only if the benefits outweigh the risks.

bannner image

Breast Feeding

Caution

The presence of this medicine in human milk is unknown. When deciding whether to stop treatment with either drug, your doctor may consider the advantages of breastfeeding for the infant and Hepalair Injection treatment for the breastfeeding mother.

bannner image

Driving

Caution

Hepalair Injection is unlikely to interfere with your ability to drive. However, drive or operate machinery only if you are alert.

bannner image

Liver

Caution

Your doctor will adjust the infusion rate of Hepalair Injection if your liver function is seriously compromised in order to stop nausea and vomiting.

bannner image

Kidney

Caution

Please consult your doctor if you have any concerns regarding the use of Hepalair Injection in patients with kidney impairment. Hepalair Injection should not be used in case of severe renal impairment.

bannner image

Children

Consult your doctor

Limited information is available regarding the usage of Hepalair Injection in children. Please consult your doctor.

Country of origin

India

Manufacturer/Marketer address

Cipla House, Peninsula Business Park, Ganpatrao Kadam Marg, Lower Parel, Mumbai-400013.
Other Info - HEP0392

Author Details

Doctor imageWe provide you with authentic, trustworthy and relevant information

FAQs

Hepalair Injection is used to treat Liver diseases include hepatitis, fatty liver, jaundice, liver cirrhosis, and hepatic encephalopathy.
Hepalair Injection removes ammonia by increasing glutamine and urea synthesis in the liver and synthesis of glutamine in brain and muscle tissues.
Nausea could be a side-effect of Hepalair Injection. It is not a common side effect in everyone who takes this medication. However, if the condition persists or worsens, consult a doctor.
Hepalair Injection converts toxic, harmful ammonia into non-toxic urea, which is eliminated via the urine. It serves as a stimulus for hepatic glutamine synthesis that could be defective in acute and chronic liver disease.
Hepalair Injection may be indicated to treat hepatic encephalopathy. It helps improve psychometric function in patients with hepatic encephalopathy. Hepatic encephalopathy is a liver disease in which the liver does not remove toxins from the body, leading to brain function loss.
Hepalair Injection may cause side effects such as nausea or vomiting in some people. However, if these side effects persist or worsen, please inform your doctor.
No, it is not recommended to take alcohol when taking Hepalair Injection. Although, the interaction of alcohol with Hepalair Injection is unknown, still alcohol should be avoided in liver failure cases as it may worsen the complication of liver disease.
Hepalair Injection will be injected into the vein by a doctor or nurse. Do not self-administer.

Disclaimer

While we strive to provide complete, accurate, and expert-reviewed content on our 'Platform', we make no warranties or representations and disclaim all responsibility and liability for the completeness, accuracy, or reliability of the aforementioned content. The content on our platform is for informative purposes only, and may not cover all clinical/non-clinical aspects. Reliance on any information and subsequent action or inaction is solely at the user's risk, and we do not assume any responsibility for the same. The content on the Platform should not be considered or used as a substitute for professional and qualified medical advice. Please consult your doctor for any query pertaining to medicines, tests and/or diseases, as we support, and do not replace the doctor-patient relationship.